APA (7th ed.) Citation

MJ, C., TT, S., J, S., D, B., F, F., C, H., . . . HU, A. (2026). Combination Cytoreductive Surgery, Radiotherapy, or Ablation for De Novo Metastatic Prostate Cancer: The IP2-ATLANTA Internal Pilot, Phase 2, Randomised Controlled Trial. European urology oncology, 9(2), 276. https://doi.org/10.1016/j.euo.2025.05.010

Chicago Style (17th ed.) Citation

MJ, Connor, et al. "Combination Cytoreductive Surgery, Radiotherapy, or Ablation for De Novo Metastatic Prostate Cancer: The IP2-ATLANTA Internal Pilot, Phase 2, Randomised Controlled Trial." European Urology Oncology 9, no. 2 (2026): 276. https://doi.org/10.1016/j.euo.2025.05.010.

MLA (9th ed.) Citation

MJ, Connor, et al. "Combination Cytoreductive Surgery, Radiotherapy, or Ablation for De Novo Metastatic Prostate Cancer: The IP2-ATLANTA Internal Pilot, Phase 2, Randomised Controlled Trial." European Urology Oncology, vol. 9, no. 2, 2026, p. 276, https://doi.org/10.1016/j.euo.2025.05.010.